Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
6 August 2026 · filed under babbff7d49db
Federal health officials have invited representatives from technology companies, research institutions, and lobbying groups to closed-door meetings on clinical artificial intelligence, according to reporting by STAT News published August 5, 2026. The meetings are described as part of an effort by regulators to boost adoption of AI tools in clinical settings.
STAT’s report identifies industry firms, researchers, and lobbyists among the invited participants. The outlet characterizes the sessions as closed-door, meaning they are not open to public observation or participation in the manner of standard rulemaking proceedings.
The report does not specify which federal agency or agencies are convening the meetings, nor does it detail a timeline for when the sessions will occur or conclude. It also does not enumerate the specific policy questions on the agenda, beyond the general aim of encouraging clinical AI adoption.
STAT’s coverage is presented under its STAT+ subscription designation, indicating the original reporting includes additional detail not reflected in the publicly available summary.
The Specola’s telescope log records this item as reported by STAT News on the date given, based solely on the headline and summary supplied. No additional sourcing beyond STAT News is cited in the available material, and no further corroborating outlets are named in this record.